The largest database of trusted experimental protocols

3 protocols using rabbit anti mef2

1

Cardiac Tissue Preparation and Immunostaining

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of each experiment, the hearts were collected and fixed overnight at 4°C in 2% paraformaldehyde. They were then rinsed in PBS and equilibrated in 30% sucrose before embedding in Tissue-Tek OCT compound (Sakura Finetek Europe B.V.) and cryo-sectioned at a thickness of 16 µm. The immunohistochemistry procedures were performed as previously described [23 (link)]. The following primary antibodies were used: rabbit anti-MCM5 at 1 : 5000 (kindly provided by Soojin Ryu, Heidelberg), mouse anti-p-Histone 3 at 1 : 200 (Millipore, Clone 3H10), rabbit anti-Mef2 at 1 : 100 (Santa Cruz Biotech SC-313), rabbit anti-DsRed (Clonetech, 632496) at 1 : 200 and rat anti-BrdU at 1 : 100 (Abcam, ab6326). To visualize the cardiac muscle, sections were incubated for 30 min with Phalloidin-Atto 647N (Sigma-Aldrich) at a dilution of 1 : 500. For the BrdU immunostaining, the slides were incubated in 2 M HCl in PBS with 0.3% Triton-X for 45 min before the immunohistochemistry procedure. The Alexa-Fluor-conjugated secondary antibodies (Jackson Immunoresearch) were used at 1 : 500, and DAPI was used at 1 : 2000. Haematoxylin and eosin (H & E) staining was performed as previously described [15 (link)].
+ Open protocol
+ Expand
2

Cardiac Muscle Proliferation Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Hearts were extracted, fixed in 4% paraformaldehyde, equilibrated in 30% sucrose, then embedded in TBS tissue freezing medium (Fisher Scientific, Hampton, NH #TFM-C) and sectioned to 10 μm. Primary antibodies used were rabbit anti-Mef2 (Santa Cruz Biotechnology, Santa Cruz, CA #SC-313; 1:75) and mouse anti-Pcna (Sigma-Aldrich, Nadick, MA #P8825; 1:400). Secondary antibodies used were Alexa Fluor 488 goat anti-rabbit IgG (H + L) for anti-Mef2, and Alexa Fluor 594 goat anti-mouse IgG (H + L) for anti-Pcna (Invitrogen - Thermo Fisher Scientific, Waltham, MA #A11034, #A11020). Images were captured at 20× using an Olympus BX53 microscope and Retiga 2000DC camera. CM proliferation indices were calculated as a percentage of Mef2(+)Pcna(+) cells relative to the total number of Mef2(+) cells in a defined area adjacent to the injury.
+ Open protocol
+ Expand
3

Transgenic Mouse Visualization and Manipulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice and Reagents PV-Cre: B6;129P2-Pvalbtm1(cre)Arbr/J was from Jackson Laboratories. PV neurons were visualized in PV-Cre x Rosa-CAG-STOP-tdTomato mice (Silvia Arber, Basel). Antibodies, goat and monoclonal mouse anti-PV (Swant, Bellinzona) 1:5,000 (goat) and 1:500 (mouse); mouse anti-GAD-67 (Chemicon) 1:500; rabbit anti-Mef2 (Santa Cruz Biotechnology, sc-313) 1:1,000; rat anti-BrdU (abcam) 1:500; mouse anti-NeuN (Millipore) 1:200; mouse anti-Bassoon (Molecular Probes) 1:200; mouse anti-Gephyrin (Molecular Probes) 1:500; biotinylated WFA (Vector laboratories), 1:500; and aBungarotoxin, Alexa 488 conjugated (Molecular Probes, Invitrogen) 1:500. Local treatments were carried out on consecutive days, through implanted cannulas (33G, Bilaney Consultants), or intraperitoneally (i.p.) (Diazepam, Roche, 3 mg/kilogram [kg] in saline; D-AP5, Tocris Bioscience, 10 mg/kg in saline). In vivo topic injections (pharmacologically selective actuator module [PSAM] virus; ChABC, 0.08 units, Sigma; Ac-Tyr 1 ,D-Phe 2 -growth-hormone releasing factor 1-29, 300 nm, Tocris) were into dorsal (coordinates, À1.58 from bregma, 1.65 mediolateral, and 1.5 dorsoventral) or ventral hippocampus (coordinates, À2.7 from Bergma, 3.25 mediolateral, and 2.25 dorsoventral). Injected solutions were less than 200 nanoliter (nl) per day.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!